Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience.
We’ve created Raremark as the place for the lived experience of rare disease.
Raremark brings together thousands of patients and caregivers who live with a rare disease, helping them to better understand, manage, and talk about the condition that's part of their life.
Members can also learn more about medical research and sign up to be informed about relevant study opportunities.
uMotif and Xperiome collaborate to bring studies to rare disease patients more quickly and effectively
Leading clinical technology providers join forces to tackle key clinical trial pain point, powering efforts to improve patient recruitment and retention in rare disease research studies
Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
Using Science 37’s decentralized clinical trials model, the partnership offers Xperiome’s research-ready, rare disease patients more study opportunities, with less burden.
Healthtech company Raremark® reboots as Xperiome™ to drive increased value for rare disease patients and researchers
In response to the exceptional growth we’re experiencing, both within the patient community and the commercial pharma environment, we are rebranding as Xperiome.